A novel deep learning segmentation model for organoid-based drug screening
Organoids are self-organized three-dimensional in vitro cell cultures derived from stem cells. They can recapitulate organ development, tissue regeneration, and disease progression and, hence, have broad applications in drug discovery. However, the lack of effective graphic algorithms for organoid g...
Main Authors: | Xiaowen Wang, Chunyue Wu, Shudi Zhang, Pengfei Yu, Lu Li, Chunming Guo, Rui Li |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-12-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2022.1080273/full |
Similar Items
-
A deep learning model for drug screening and evaluation in bladder cancer organoids
by: Shudi Zhang, et al.
Published: (2023-04-01) -
Patient-Derived Organoids in Precision Medicine: Drug Screening, Organoid-on-a-Chip and Living Organoid Biobank
by: Zilong Zhou, et al.
Published: (2021-12-01) -
Drug screening model meets cancer organoid technology
by: Chen Liu, et al.
Published: (2020-11-01) -
The role of organoids in cancer research
by: Zhen Fang, et al.
Published: (2023-08-01) -
Organoid Models of Glioblastoma and Their Role in Drug Discovery
by: Matthew J. Rybin, et al.
Published: (2021-02-01)